Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Bacteria may be associated with risk of MS relapse

Publish date:: October 7, 2020

Key clinical point: Differences in the gut microbiome may affect the risk of relapse in pediatric-onset MS.

Major finding: Blautia stercoris had the most significant association with relapse risk (HR, 2.50).

Study details: An examination of stool samples from 53 patients with pediatric-onset MS.

Disclosures: The National MS Society and the National Institute of Neurological Disorders and Stroke funded the study. Ms. Horton had no disclosures.

Citation:

Horton M et al. MSVirtual2020, Abstract LB01.05.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Multiple Sclerosis

Long-term safety and efficacy of teriflunomide for relapsing MS,

Newer DMTs are more effective than injectable DMTs in pediatric MS,

Neutrophil granulocyte markers may distinguish between demyelinating diseases,

Bacteria may be associated with risk of MS relapse,

Women with MS may have increased subclinical disease activity during pregnancy,